Global private equity firm Bain Capital has officially acquired UK-based nutraceutical company Vitabiotics for $850-900 million, as confirmed by The Economic Times. The deal includes the acquisition of Meyer Organics in India, along with its operations in Africa and Egypt. The acquisition strengthens Bain Capital's presence in the global wellness sector as demand for vitamins and nutritional supplements continues to grow since the pandemic. The companies declined to disclose the financial terms of the transaction, but people familiar with the matter confirmed the deal is valued at about $850-900 million. Bain Capital has emerged as the frontrunner after two other contenders, TPG Capital and EQT, opted out of the competitive bidding process.
The investment will be led by Bain Capital's Asia Private Equity team and supported by the firm's global platform. As reported by The Economic Times, Bain Capital will bring local market knowledge in India, together with sector expertise, portfolio resources and global capabilities, to support Vitabiotics as it continues to scale its brands and strengthen its international platform. Pawan Singh, partner at Bain Capital, stated that the firm sees a compelling opportunity to help Vitabiotics build on its UK leadership and strengthen its global platform. The UK will remain central to Vitabiotics' brand, innovation, and category leadership, with no immediate changes to day-to-day operations. The Asia Private Equity team leading the investment signals where Bain Capital sees the primary growth opportunity, with India and Asia's expanding middle class representing a substantially larger long-term market than the mature UK and European supplement space.
Vitabiotics was founded in 1971 by scientist and entrepreneur Kartar Lalvani, who pioneered the nutraceutical field and innovative science-based formulas, leading to whole new categories of supplements and sector-leading brands. According to The Economic Times, its portfolio of brands includes Pregnacare, Perfectil, Wellman, Wellwoman, Osteocare, and the Ultra range. The company markets its health supplement and wellness products in India through Meyer Organics, giving it established distribution and brand presence in one of the world's fastest-growing consumer health markets. Under group CEO Tej Lalvani, who has led the business over the past decade after more than 30 years with the company and was a former investor on the BBC television show Dragons' Den, the business has seen accelerated growth through product launches and partnerships. The Vitabiotics Group is present across several markets, including India, China, Egypt and the wider MENA region.
As reported by The Economic Times, the company will focus on delivering for customers, partners and consumers, while also investing in areas including digital capabilities, e-commerce, international distribution, supply chain resilience and new product development. Pawan Singh noted that the India team has deep experience partnering with healthcare and consumer businesses and looks forward to supporting Vitabiotics' next phase of growth. Following the transaction, founder Kartar Lalvani will become chairman emeritus, while his elder son, Ajit Lalvani, will continue as a non-executive director. Tej Lalvani will continue as group CEO through and after the transition, with the deal marking a shift in ownership rather than a change in management. The arrangement reflects the value Bain Capital sees in the leadership team that built the company into its current position, with the founder taking on an honorary role that acknowledges his foundational contribution while reflecting the change in control the transaction represents.
